Inforlife Drug Patent Portfolio
Inforlife owns 2 orange book drugs protected by 5 US patents Given below is the list of Inforlife's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10888534 | Storage stable ready-to-use norepinephrine aqueous solutions in flexible plastic bags | 26 Apr, 2039 | Active |
| US10966990 | Midazolam in flexible bags | 20 Jun, 2038 | Active |
| US10251848 | Process for producing a stable low concentration, injectable solution of noradrenaline | 26 Feb, 2035 | Active |
| USRE49422 | Process for producing a stable low concentration, injectable solution of noradrenaline | 26 Feb, 2035 | Active |
| USRE49443 | Process for producing a stable low concentration, injectable solution of noradrenaline | 26 Feb, 2035 | Active |
Latest Legal Activities on Inforlife's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Inforlife.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Recordation of Patent Grant Mailed | 11 Mar, 2025 | US12245996 |
| Patent Issue Date Used in PTA Calculation | 11 Mar, 2025 | US12245996 |
| Patent eGrant Notification | 11 Mar, 2025 | US12245996 |
| Recordation of Patent eGrant | 11 Mar, 2025 | US12245996 |
| Mail Patent eGrant Notification | 11 Mar, 2025 | US12245996 |
| Email Notification | 11 Mar, 2025 | US12245996 |
| Issue Notification Mailed | 19 Feb, 2025 | US12245996 |
| Email Notification | 19 Feb, 2025 | US12245996 |
| Application Is Considered Ready for Issue | 03 Feb, 2025 | US12245996 |
| Dispatch to FDC | 03 Feb, 2025 | US12245996 |
| Issue Fee Payment Received | 31 Jan, 2025 | US12245996 |
| Issue Fee Payment Verified | 31 Jan, 2025 | US12245996 |
| Mail Corrected Notice of Allowance | 20 Dec, 2024 | US12245996 |
| Corrected Notice of Allowance | 19 Dec, 2024 | US12245996 |
| Mail Notice of Allowance | 18 Dec, 2024 | US12245996 |
Inforlife's Family Patents
Inforlife Drug List
Given below is the complete list of Inforlife's drugs and the patents protecting them.
1. Midazolam In 0.9% Sodium Chloride
Midazolam In 0.9% Sodium Chloride is protected by 1 patent, which is still active. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10966990 | Midazolam in flexible bags |
20 Jun, 2038
(12 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Midazolam In 0.9% Sodium Chloride's drug page
2. Norepinephrine Bitartrate In 0.9% Sodium Chloride
Norepinephrine Bitartrate In 0.9% Sodium Chloride is protected by 4 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10888534 | Storage stable ready-to-use norepinephrine aqueous solutions in flexible plastic bags |
26 Apr, 2039
(13 years from now)
| Active |
| US10251848 | Process for producing a stable low concentration, injectable solution of noradrenaline |
26 Feb, 2035
(8 years from now)
| Active |
| USRE49422 | Process for producing a stable low concentration, injectable solution of noradrenaline |
26 Feb, 2035
(8 years from now)
| Active |
| USRE49443 | Process for producing a stable low concentration, injectable solution of noradrenaline |
26 Feb, 2035
(8 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Norepinephrine Bitartrate In 0.9% Sodium Chloride's drug page